Features of amiodarone-induced optic neuropathy

American Journal of Ophthalmology

Volumn 127, Issue 5, 1999, Pages 610-612

  MacAluso, Damien C ^a   Shults, William T ^a   Fraunfelder, Frederick T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; HEART ARRHYTHMIA; HUMAN; ISCHEMIC OPTIC NEUROPATHY; MAJOR CLINICAL STUDY; OPTIC NERVE DISEASE; PAPILLEDEMA; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

EID: 0032962579     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00016-1     Document Type: Article

References (3)

1. Feiner L.A., Younge B.R., Kazmier F.J., Stricker B.H., Fraunfelder F.T. Optic neuropathy and amiodarone therapy. Mayo Clin Proc. 62:1987;702-717.
2. Mansour A.M., Puklin J.E., O'Grady R. Optic nerve ultrastructure following amiodarone therapy. J Clin Neuroophthalmol. 8:1988;231-237.
3. Latini R., Tognoni G., Kates R.E. Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet. 9:1984;136-156.